Cargando…

Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis

Purpose. To assess the efficacy and safety of adalimumab in patients with juvenile idiopathic arthritis (JIA) and associated refractory uveitis. Design. Multicenter, prospective case series. Methods. Thirty-nine patients (mean [SD] age of 11.5 [7.9] years) with JIA-associated uveitis who were either...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-De-Vicuña, Carmen, Díaz-Llopis, Manuel, Salom, David, Bou, Rosa, Díaz-Cascajosa, Jesus, Cordero-Coma, Miguel, Ortega, Gabriela, Ortego-Centeno, Norberto, Suarez-De-Figueroa, Marta, Cruz-Martínez, Juan, Fonollosa, Alex, Blanco, Ricardo, García-Aparicio, Ángel María, Benítez-Del-Castillo, Jose M., Antón, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892756/ https://www.ncbi.nlm.nih.gov/pubmed/24489444 http://dx.doi.org/10.1155/2013/560632

Ejemplares similares

Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis
por: Márquez, Ana, et al.
Publicado: (2013)

No Evidence of Association between Common Autoimmunity STAT4 and IL23R Risk Polymorphisms and Non-Anterior Uveitis
por: Cénit, María Carmen, et al.
Publicado: (2013)

Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition
por: Cénit, María Carmen, et al.
Publicado: (2013)

Lack of association between the protein tyrosine phosphatase non-receptor type 22 R263Q and R620W functional genetic variants and endogenous non-anterior uveitis
por: Cénit, María Carmen, et al.
Publicado: (2013)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Levels of thrombopoietin in aqueous humor of patients with noninfectious acute anterior uveitis
por: Mondejar, José-Juan, et al.
Publicado: (2015)

Effectiveness of adalimumab in the treatment of juvenile idiopathic arthritis associated with uveitis
por: Zholobova, Elena, et al.
Publicado: (2014)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
por: Lanz, Sofia, et al.
Publicado: (2021)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
por: Joos, R, et al.
Publicado: (2011)

Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis
por: Kotaniemi, Kaisu, et al.
Publicado: (2011)

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
por: Acharya, Nisha R., et al.
Publicado: (2020)

Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study
por: Rivas, Ana Belen, et al.
Publicado: (2022)

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
por: Vougiouka, O, et al.
Publicado: (2011)

Adalimumab for refractory peripheral ulcerative keratitis
por: Cordero-Coma, Miguel, et al.
Publicado: (2012)

Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series
por: La Torre, Francesco, et al.
Publicado: (2014)

Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis
por: Pato-Cour, Esperanza, et al.
Publicado: (2023)

Development of an activity disease score in patients with uveitis (UVEDAI)
por: Pato, Esperanza, et al.
Publicado: (2016)

Profile of adalimumab and its potential in the treatment of uveitis
por: Balevic, Stephen J, et al.
Publicado: (2016)

Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis
por: Pato-Cour, Esperanza, et al.
Publicado: (2023)

Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet's Disease, Sarcoidosis, and Noninfectious Uveitis
por: Sánchez-Cano, Daniel, et al.
Publicado: (2013)

Aqueous humor neutrophil gelatinase-associated lipocalin levels in patients with idiopathic acute anterior uveitis
por: Salom, David, et al.
Publicado: (2010)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
por: Al-Julandani, DA, et al.
Publicado: (2023)

Editorial: Multimodal imaging in uveitis
por: Fonollosa, Alex, et al.
Publicado: (2022)

Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry
por: Vitale, Antonio, et al.
Publicado: (2023)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis
por: Mase, Oliver, et al.
Publicado: (2023)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2013)

Clinical benefits and potential risks of adalimumab in non‐JIA chronic paediatric uveitis
por: Kouwenberg, Carlyn V., et al.
Publicado: (2021)

Juvenile Spondyloarthritis: focus on uveitis
por: Marino, Achille, et al.
Publicado: (2020)

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
por: Erckens, R. J., et al.
Publicado: (2011)

Adalimumab in patients with vision-threatening uveitis: real-world clinical experience
por: Tang Lee Say, Timothy Lee, et al.
Publicado: (2021)

Adalimumab in Treatment of Uveitis in Pediatric Behcet’s Disease–a Case Report
por: Halilbasic, Meliha, et al.
Publicado: (2021)

Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
por: Giani, TG, et al.
Publicado: (2008)

Q fever: a new ocular manifestation
por: Udaondo, P, et al.
Publicado: (2011)

Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2019)

Acute endothelial failure after cosmetic iris implants (NewIris(®))
por: Garcia-Pous, Maria, et al.
Publicado: (2011)

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
por: Udaondo, Patricia, et al.
Publicado: (2011)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo, Patricia, et al.
Publicado: (2011)

Alternative ultraviolet A lamp for corneal collagen crosslinking
por: Diaz-Llopis, Manuel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h80nt67bo32cddlugkrhm7uijf